We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth (UNH) Q2 Earnings Beats, Revenues in Line
Read MoreHide Full Article
Have you been eager to see how UnitedHealth Group Inc. (UNH - Free Report) performed in Q2 in comparison with the market expectations? Let’s quickly scan through the key facts from this leading health insurance company’s earnings release this morning.
An Earnings Beat
UnitedHealth came out with adjusted earnings per share of $2.46, beating the Zacks Consensus Estimate of $2.38.
Better-than-expected earnings were primarily due to higher revenues and share buyback.
How Was the Estimate Revision Trend?
The earnings estimate revisions for UnitedHealth did not show a major change prior to the earnings release. The Zacks Consensus Estimate has moved just 0.1% higher over the last seven days.
But the same has increased 3.2% over the past 90 days.
Before posting earnings beat in Q2, the company delivered positive surprises in each of the trailing four quarters.
As a result, the company overall surpassed the Zacks Consensus Estimate by an average of 4.6% in the trailing four quarters.
Revenue Came In Line
UnitedHealth posted revenues of $50.1 billion, in line with the Zacks Consensus Estimate. The reported figure was up from 7.7% from the year-ago quarter.
UnitedHealth Group Incorporated Price and EPS Surprise
Consolidated medical care ratio of 82.2% increased 20 basis points year-over-year.
Operating cost ratio of 14.6% was flat year-over-year.
The company medical enrollment grew to 49.5 million from 48 million in the year-ago quarter.
Cash flows from operations were $2.2 billion up 29% year-over-year.
Guidance Update
Followed by strong earnings performance in the first-half of 2017, the company raised its outlook for 2017 GAAP net earnings to a range of $9.20 to $9.35 per share and adjusted net earnings to a range of $9.75 to $9.90 per share.
Check back later for our full write up on this UnitedHealth earnings report!
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth (UNH) Q2 Earnings Beats, Revenues in Line
Have you been eager to see how UnitedHealth Group Inc. (UNH - Free Report) performed in Q2 in comparison with the market expectations? Let’s quickly scan through the key facts from this leading health insurance company’s earnings release this morning.
An Earnings Beat
UnitedHealth came out with adjusted earnings per share of $2.46, beating the Zacks Consensus Estimate of $2.38.
Better-than-expected earnings were primarily due to higher revenues and share buyback.
How Was the Estimate Revision Trend?
The earnings estimate revisions for UnitedHealth did not show a major change prior to the earnings release. The Zacks Consensus Estimate has moved just 0.1% higher over the last seven days.
But the same has increased 3.2% over the past 90 days.
Before posting earnings beat in Q2, the company delivered positive surprises in each of the trailing four quarters.
As a result, the company overall surpassed the Zacks Consensus Estimate by an average of 4.6% in the trailing four quarters.
Revenue Came In Line
UnitedHealth posted revenues of $50.1 billion, in line with the Zacks Consensus Estimate. The reported figure was up from 7.7% from the year-ago quarter.
UnitedHealth Group Incorporated Price and EPS Surprise
UnitedHealth Group Incorporated Price and EPS Surprise | UnitedHealth Group Incorporated Quote
Key Stats to Note
Consolidated medical care ratio of 82.2% increased 20 basis points year-over-year.
Operating cost ratio of 14.6% was flat year-over-year.
The company medical enrollment grew to 49.5 million from 48 million in the year-ago quarter.
Cash flows from operations were $2.2 billion up 29% year-over-year.
Guidance Update
Followed by strong earnings performance in the first-half of 2017, the company raised its outlook for 2017 GAAP net earnings to a range of $9.20 to $9.35 per share and adjusted net earnings to a range of $9.75 to $9.90 per share.
What Zacks Rank Says
UnitedHealth carries a Zacks Rank #2 (Buy). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here).
Check back later for our full write up on this UnitedHealth earnings report!
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>